FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.
The aim of the present study was to identify agents capable of inhibiting the invasion and metastasis of tongue squamous cell carcinoma and thereby improve the outcomes of patients suffering from tongue cancer. FRMD4A antibodies were used to probe 78 paraffin-embedded specimens of tongue squamous cell carcinoma and 15 normal tongue tissues, which served as controls. Immunohistochemical methods were then used for analysis. Clinical pathological parameters were obtained, and the association between FRMD4A expression in the samples and the pathological parameters was analyzed. The human tongue cancer cell line CAL27 was used to study the effects of FRMD4A. CAL27 cells were transfected with small-interfering RNA against FRMD4A (FRMD4A-siRNA) and the mRNA and protein levels of FMRD4A were then evaluated by RT-qPCR and western blot analysis, respectively. The proliferation and cell-cycle assays of CAL27 cells were evaluated using the CCK8 method and flow cytometry. The invasion and migration of the cells were measured using a Matrigel invasion chamber and a scratch assay, respectively. The results showed FRMD4A overexpression in tongue squamous cell carcinoma, and the positive reaction was predominately located in the cytoplasm. Tumor clinical stage and lymph node metastasis showed a statistically significant correlation with FRMD4A expression. Transient silencing of the FRMD4A gene for 24 and 48 h significantly decreased the mRNA and protein expression of FRMD4A, respctively. Silencing FRMD4A gene reduced the proliferation of CAL27 cells and led to cell cycle arrest in the G1 phase, as well as significantly suppressing the migration and invasion capacity of CAL27 cells. The findings of the present study suggest that FRMD4A expression correlates with the development of tongue squamous cell carcinoma. For this reason, FRMD4A merits further study as it may be suitable for use as a therapeutic agent in antitumor treatment regimens.
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Xianghuai
X
Zheng
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Bo
B
Jia
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Xi
X
Lin
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Jiusong
J
Han
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Xiaoling
X
Qiu
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Hongxing
H
Chu
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Xiang
X
Sun
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Weitao
W
Hu
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Jie
J
Pan
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Jun
J
Chen
Laboratory for Oral Diseases, Department of Oral Surgery, Guangdong Provincial Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China.
Jianjiang
J
Zhao
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics* / Q000378:metabolism; D015153:Blotting, Western; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002453:Cell Cycle / Q000235:genetics; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation / Q000235:genetics; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D034622:RNA Interference; D012189:Retrospective Studies; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014062:Tongue Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology
D048868:Adaptor Proteins, Signal Transducing; C574784:FERM domain-containing protein 4A, human
Hum Genet. 2012 Jun;131(6):1009-21
22006218
Dev Growth Differ. 2010 Sep;52(7):591-602
20887560
Biochim Biophys Acta. 2007 May;1773(5):653-60
16904765
Oral Oncol. 2011 Jan;47(1):45-50
21167767
Protein J. 2011 Oct;30(7):499-508
21947960
Oral Oncol. 2010 Apr;46(4):226-31
20138569
Nature. 1998 Feb 19;391(6669):806-11
9486653
Science. 2003 Oct 31;302(5646):875-8
14593182
Clin Otolaryngol. 2010 Aug;35(4):307-12
20738340
Physiol Rev. 2001 Jul;81(3):1353-92
11427698
BMC Med Genet. 2008 Dec 18;9:113
19094236
Cancer Metastasis Rev. 2007 Dec;26(3-4):645-62
17768600
Clin Exp Otorhinolaryngol. 2008 Sep;1(3):166-70
19434251
Biochem Biophys Res Commun. 2006 Nov 17;350(2):405-12
17010315
Cancer Res. 2012 Jul 1;72(13):3424-36
22564525
Front Biosci (Landmark Ed). 2011 Jan 01;16:1536-50
21196246
Semin Cancer Biol. 2008 Apr;18(2):79-88
18291671
Curr Opin Genet Dev. 2009 Aug;19(4):357-67
19596566
J Oncol. 2009;2009:412908
19696947
Curr Opin Genet Dev. 2002 Feb;12 (1):47-52
11790554
Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):748-53
20080746
Lancet. 2000 Dec 9;356(9246):1981-2
11130529